4Goldstraw P. The 7th Edition of TNM in Lung Cancer: what now J 3. J Thorac Oncol, 2009, 4(6): 671-3.
5Kligerman S, Digumarthy S. Staging of non-small cell lung cancer using integrated PET/CT[J ]. Am J Roentgenol, 2009, 193(5):1203 - 11.
6West H, Harpole D, Travis W. Histologic considerations for individualized systemic therapy approaches for the management of non-small cell lung cancer[J]. Chest, 2009, 136(4): 1112-8.
7Sanli M, Isik AF, Zincirkeser S, et al. Reliability of positron emission tomog raphy-computed tomography in identification of mediastinal lymph node status in patients with non-small cell lung cancer[J]. J Thorac Cardiovasc Surg, 2009, 138(5): 1200-5.
8Gould MK, Kuschner WG, Rydzak CE, et al. Test performance of positron emission tomography and computed tomography for mediast inal staging in patients with non-small-cell lung cancer: a meta analysis[J]. Ann Intern Med, 2003, 139: 879-92.
9Weng E, Tran L, Rege S, et al. Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer[J]. Am J Clin Oncol, 2000, 23:47-52.
10Kelly RF, Tran T, Holmstrom A, et al. Accuracy and cost- effectiveness of [ ^18F ]-2-fluoro deoxy-D- glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer [J]. Chest, 2004, 125: 413-23.
